APA (7th ed.) Citation

Zhang, Y., Widart, J., Ziemons, E., Hubert, P., & Hubert, C. N-nitrosamine risk assessment in pharmaceuticals: Where are we from a regulatory point of view in 2025? Elsevier.

Chicago Style (17th ed.) Citation

Zhang, Yue, Joëlle Widart, Eric Ziemons, Philippe Hubert, and Cédric Hubert. N-nitrosamine Risk Assessment in Pharmaceuticals: Where Are We from a Regulatory Point of View in 2025? Elsevier.

MLA (9th ed.) Citation

Zhang, Yue, et al. N-nitrosamine Risk Assessment in Pharmaceuticals: Where Are We from a Regulatory Point of View in 2025? Elsevier.